New drug tested to stop aggressive kidney Cancer's return
NCT ID NCT06584435
Summary
This study is testing whether a drug called toripalimab can prevent kidney cancer from coming back after surgery. All 100 participants, who have high-risk kidney cancer that was surgically removed, will receive the drug by IV every 3 weeks for about a year. Researchers will monitor patients with regular scans and check-ups to see if the treatment safely extends the time they live cancer-free.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH-RISK RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Changyi Quan
Tianjin, Tianjin Municipality, 300211, China
Conditions
Explore the condition pages connected to this study.